Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 65 years of age or older
- People who have dry age-related macular degeneration (a condition affecting the central part of the retina) in both eyes
- People whose vision, when tested with a standard eye chart using corrective lenses, falls within a specific range — between 1/10 and 4/10 (confirm with trial site for exact details)
- People who do not have other eye conditions (such as glaucoma or amblyopia/lazy eye) or other health conditions that could affect the main measurements of the trial
- People who are willing and able to sign a consent form agreeing to participate
Who may not be able to join:
- People under 65 years of age
- People who are pregnant
- People who have had a previous infection or inflammation affecting the eyes
- People with a history of eye injury, diabetes, or any condition that could potentially harm the visual system, even if no vision problems are currently present
- People who have previously received injections of medication into the eye (intravitreal treatments)
- People who are unwilling to sign the consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0630151
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Autofluorescence atrophy area changes in treated eyes compared with sham group
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.